DCGI

New Delhi: A day ahead of the scheduled dry run for vaccination in all the states, a government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the…

New Delhi: Drug firm Zydus Cadila has received approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in…

New Delhi: The Bharat Biotech developed-vaccine in collaboration with the Indian Council of Medical Research (ICMR) — Covaxin — has got the approval for the third phase of clinical trials.…

New Delhi: The Indian Council of Medical Research (ICMR) has developed an ‘antisera’ for the treatment of coronavirus. It has been approved by the Drugs Controller General of India (DCGI)…

Pune: The Serum Institute of India (SII) will start the third and final phase of human trial of Oxford-Astrazeneca’s coronavirus vaccine at Pune’s Sasson General Hospital early next week.…

New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of India (SII) has been suspended by the Drugs…

New Delhi: The Drugs Controller General of India (DCGI) has given green signal to Pune-based Serum Institute of India (SII) to conduct the phase 2 and 3 of clinical human trials of the…

New Delhi: Drug firm Hetero has received approval from Drug Controller General of India (DCGI) to manufacture and market antiviral drug Remdesivir for the treatment of COVID-19. The DCGI…

New Delhi: Four Covid-19 hospitals in India have received clearance to be part of the World Health Organisation’s (WHO) clinical trial process to find an effective treatment for the novel…